Literature DB >> 25875209

6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells.

Aiga Grandane1, Muhammet Tanc2,3, Lorenzo Di Cesare Mannelli4, Fabrizio Carta3, Carla Ghelardini4, Raivis Žalubovskis1, Claudiu T Supuran2,3.   

Abstract

6-Substituted sulfocoumarins bearing the carboxamido, trimethylammonium as well as the cyano and methoxy moieties with interesting inhibitory activity/selectivity against the tumor associated carbonic anhydrase (CA, EC 4.2.1.1) isoforms hCA IX and XII are reported. Moieties leading to the best inhibition were tert-butylcarboxamido, phenylcarboxamido, and 4-pyridylcarboxamido, with K(I) values of 2.1-8.1 nM. No inhibition of the off-target hCA II and I was observed. A number of these compounds were evaluated against HT-29 colon cancer cell lines ex vivo. Compounds 9c and 9e revealed effective cytotoxic effects after 72 h of incubation in both normoxic and hypoxic conditions, unlike sulfonamide CA inhibitors that show such effects only in hypoxia. These results may be of particular importance for the choice of future drug candidates targeting hypoxic tumors and metastases, considering the fact that a sulfonamide CA IX inhibitor (SLC-0111) is presently in phase I clinical trials.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25875209     DOI: 10.1021/acs.jmedchem.5b00523

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  13 in total

1.  Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII.

Authors:  Simone Giovannuzzi; Clemente Capasso; Alessio Nocentini; Claudiu T Supuran
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

2.  Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.

Authors:  Mikhail Krasavin; Stanislav Kalinin; Tatiana Sharonova; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

3.  Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides.

Authors:  Rita Meleddu; Simona Distinto; Filippo Cottiglia; Rossella Angius; Marco Gaspari; Domenico Taverna; Claudia Melis; Andrea Angeli; Giulia Bianco; Serenella Deplano; Benedetta Fois; Sonia Del Prete; Clemente Capasso; Stefano Alcaro; Francesco Ortuso; Matilde Yanez; Claudiu T Supuran; Elias Maccioni
Journal:  ACS Med Chem Lett       Date:  2018-09-17       Impact factor: 4.345

4.  Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors.

Authors:  Claudia Melis; Rita Meleddu; Andrea Angeli; Simona Distinto; Giulia Bianco; Clemente Capasso; Filippo Cottiglia; Rossella Angius; Claudiu T Supuran; Elias Maccioni
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-24       Impact factor: 5.051

5.  Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.

Authors:  Luciana Stanica; Mihaela Gheorghiu; Miruna Stan; Cristina Polonschii; Sorin David; Dumitru Bratu; Anca Dinischiotu; Claudiu T Supuran; Eugen Gheorghiu
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

6.  Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors.

Authors:  Belma Zengin Kurt; Fatih Sonmez; Serdar Durdagi; Busecan Aksoydan; Ramin Ekhteiari Salmas; Andrea Angeli; Mustafa Kucukislamoglu; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

7.  7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors.

Authors:  Aleksandrs Pustenko; Alessio Nocentini; Anastasija Balašova; Mikhail Krasavin; Raivis Žalubovskis; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

8.  PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide.

Authors:  Shimpei Iikuni; Hiroyuki Watanabe; Yoichi Shimizu; Yuji Nakamoto; Masahiro Ono
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.240

9.  Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation.

Authors:  Sheida Nasr Esfahani; Mohammad Sadegh Damavandi; Parisa Sadeghi; Zahrasadat Nazifi; Azhar Salari-Jazi; Ahmad Reza Massah
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

10.  The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors.

Authors:  Aleksandrs Pustenko; Alessio Nocentini; Paola Gratteri; Alessandro Bonardi; Igor Vozny; Raivis Žalubovskis; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.